11th annual ADMET conference and exhibition
London, UK (June, 13 – 14, 2016)
The SMi Group is proud to announce the return of the 11th annual ADMET conference taking place in London on the 13th - 14th June.
This event will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.
ADMET 2016 will provide a series of practical case studies, interactive roundtables and panel discussions facilitated by leading industry experts that will provide executives with useful tools and best practices to:
- Discover application of PBPK to drug development in rare diseases
- Review the role of drug transporters in drug delivery to CNS diseases
- Learn about better models for understanding, predicting and avoiding drug induced liver injury
- Discuss in silico approaches to evidence-based mechanistic modelling
- Analyse early dose predictions - a valuable tool in risk assessment and optimisation of small molecules
2016 Speaker Line up:
CHAIRMAN:
- Thierry Lave, Head DMPK Discovery and Development Project Leaders (CNS/CVM), Roche
KEYNOTE SPEAKERS:
- Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis
- Kunal Taskar, Senior Investigator, DMPK, GSK
- Karelle Menochet, Principal Scientist DMPK, UCB Pharma
- Laurent Salphati, Senior Scientist, Genentech
- Carl Petersson, DMPK NCE Senior Designer, Merck Serono
- Lena Gustavsson, Head of Sections Drug-Drug Interactions, Lundbeck
How to register:
EARLY BIRD offers available
Visit the event website www.admet-event.com/gate2biotech or contact Matthew Apps on 02078276093 or mapps@smi-online.co.uk
